1. Dygai AM, Zyuz’kov GN, Zhdanov VV, Udut EV, Khrichkova TYu, Miroshnichenko LA, Simanina EV, Stavriva LA. Methodical recommendations for studying specific activity of agents for regenerative medicine. Manual for Preclinical Studies of New Pharmacological Substances. Mironov AN, ed. Moscow, 2013. Part I. P. 776-787. Russian.
2. Zyuz’kov GN, Udut EV, Miroshnichenko LA, Polyakova TYu, Chaikovskii AV, Firstova OA, Lopatina KA, Safonova EA. Potential bivalency of cAMP-mediated signaling in stromal progenitor cells of the hemopoiesis-inducing microenvironment. Eskp. Klin. Farmakol. 2017;80(6, Suppl):13-14. Russian.
3. Zyuzkov GN, Zhdanov VV, Danilets MG, Miroshnichenko LA, Udut EV, Dygaj AM. Patent RU No. 2599289. Tissue regeneration stimulating agent. Bull. No. 28. Published October 10, 2016.
4. Brown JR, Cornell K, Cook PW. Adenosine- and adenine-nucleotide-mediated inhibition of normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport. J. Invest. Dermatol. 2000;115(5):849-859.
5. Du L, Lyle CS, Obey TB, Gaarde WA, Muir JA, Bennett BL, Chambers TC. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J. Biol. Chem. 2004;279(12):11 957-11 966.